Parathyroid Carcinoma: What to Do When Surgical Re-Exploration Did Not Control Hypercalcemia
In recurrent parathyroid carcinoma, surgical re-exploration is an established first intervention. When that approach does not adequately lower blood calcium — leaving hypercalcemia clinically unmanageable — a further line of treatment is indicated.
Previous treatment & escalation trigger
The preceding approach — cervical and/or mediastinal exploration with wide resection, and metastatectomy where technically feasible — aims to lower blood calcium so that hypercalcemia becomes more medically manageable. Escalation to the current protocol is appropriate when that goal is not reached.
Next-step approach (partial overview)
This protocol considers adjuvant radiation therapy or adjuvant chemotherapy regimens following resection, with the appropriate approach determined on an individual basis. The complete structured regimen — including all options, selection criteria, and sequencing — is available below.
References
DOI: 10.1007/s11864-011-0171-3
However, anecdotal reports from contemporary single institution case series have described a reduction in cancer recurrence in patients who received radiation therapy, dosed between 40 and 70 Gy after initial surgical resection.
Incorporation of adjuvant radiotherapy for the management of parathyroid carcinoma should be determined on an individual basis.
The few successful chemotherapy regimens reported in these cases include: monotherapy using dacarbazine; a combination therapy consisting of fluorouracil, cyclophosphamide, and dacarbazine; and a combination of methotrexate, doxorubicin, cyclophosphamide, and lomustine.
Use of adjuvant chemotherapy for the management of parathyroid carcinoma should be determined on an individual basis.
View source ↗